Full Text
HTA172 Type of Clinical Evidence and Its Impact on Price Reductions for Oncology Drugs: A Review of Reimbursement Submissions in Canada

Abstract

Authors

C Balijepalli L Gullapalli K Yan A Sharma E Druyts N Rawson

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×